Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø

XClose

Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø News

Home
Menu

'Game-changing’ Alzheimer’s drug lecenemab rejected by EU

29 July 2024

“This conservative approach means that patients and doctors eager to explore a proven effective drug are now denied access," explains Professor Bart De Strooper (Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Queen Square Institute of Neurology).

, , , , ,